Affimed is a pioneering brand revolutionizing cancer treatment. Comprised of passionate and experienced individuals, our expert team of biotechnology and pharmaceutical professionals is dedicated to improving the lives of patients. Inspired by the immense potential of the innate immune system, we strive to bring new hope to those affected by cancer.

With our unparalleled expertise in innate immunity, tumor biology, and antibody engineering, we are at the forefront of activating the innate immune system to fight cancer. Our proprietary technology allows us to develop groundbreaking treatments for various tumor types. We utilize our Redirected Optimized Cell Killing (ROCK) platform and innate cell engager (ICE) molecules to redirect immune cells and effectively recognize and eliminate tumor cells.

Discover the power of our innovative approach and explore our broad pipeline of ICE molecules, both as monotherapies and in combination with other immunotherapies. Through strategic partnerships, we aim to advance our clinical programs and unlock the full potential of innate immune cells in oncology. Join us in driving the revolution in cancer treatment and together, let's stop cancer from derailing patients' lives.

Visit our website for more information